Cumulative incidence of TRM in the total cohort. Cumulative incidence of TRM in the total cohort (A-B), all ALL patients (C), and AML patients (D) receiving CloFluBu conditioning. Two-year TRM with standard errors is provided, with P values calculated with the Fine and Gray model for competing risk analysis and correction for covariates where appropriate (Table 2; supplemental Table 1). Patients at risk are depicted below each survival plot.